Market cap | $351.90B |
---|---|
Enterprise value | $378.25B |
Revenue | $80.461B |
---|---|
EBITDA | $21.364B |
Income | $14.287B |
Revenue Q/Q | 1.35% |
Revenue Y/Y | 4.31% |
P/E | 29.35 |
---|---|
Forward P/E | 26.18 |
EV/Sales | 4.70 |
EV/EBITDA | 17.71 |
EV/EBIT | 20.39 |
PEG | 4.96 |
Price/Sales | 4.37 |
P/FCF | 26.67 |
Price/Book | 8.55 |
Book/Share | 18.31 |
Cash/Share | 2.83 |
FCF yield | 3.75% |
Volume | 166.000 / 1.582k |
---|---|
Relative vol. | 0.10 × |
EPS | 5.33 |
---|---|
EPS Q/Q | N/A |
Est. EPS Q/Q | N/A |
Profit margin | 18.38% |
---|---|
Oper. margin | 23.06% |
Gross margin | 47.65% |
EBIT margin | 23.06% |
EBITDA margin | 26.55% |
Ret. on assets | 12.27% |
---|---|
Ret. on equity | 32.85% |
ROIC | 13.12% |
ROCE | 23.29% |
Debt/Equity | 1.54 |
---|---|
Net debt/EBITDA | 4.44 |
Current ratio | 0.62 |
Quick ratio | 0.41 |
Volatility | 1.19% |
---|---|
Beta | 0.39 |
RSI | 61.28 |
---|
Insider ownership | 0.12% |
---|---|
Inst. ownership | 65.74% |
Shares outst. | 2.420B |
---|---|
Shares float | 2.367B 97.81% |
Short % of float | N/A |
Short ratio | N/A |
Dividend | €3.83 |
---|---|
Dividend yield | 2.48% |
Payout ratio | 71.78% |
Payment date | N/A |
Ex-dividend date | N/A |
Earnings date | N/A |
Thursday, 13 June 2024
|
|
As CEOs focus on stopping corporate tax hikes, Biden's team makes case to them on global alliances | |
Monday, 27 May 2024
|
|
2 Ray Dalio Dividend Stocks To Add To Your Portfolio In June | |
Sunday, 26 May 2024
|
|
Is Procter & Gamble Co the Best Dividend Aristocrat Stock To Buy Now? | |
Tuesday, 14 May 2024
|
|
Is Great Ajax Corp the Best High-Dividend Penny Stock to Buy Now? | |
Dividends
Ex-dividend date | 20 Oct 2022 | Frequency | Quarterly | Annual dividend | +3.48% |
---|---|---|---|---|---|
Next dividend | N/A | Dividend yield | 2.48% | Growth period | 4 years |
Last dividend date | Yield 3 years | 2.62% | Growth 3 years | +6.21% | |
Last dividend | Yield 5 years | 2.59% | Growth 5 years | N/A |
Insider | Age | Since | Compensation |
---|---|---|---|
David S. Taylor (63) Exec. Chairman | 63 | €8,616,573 | |
Jon R. Moeller (57) Pres, CEO, and Vice Chairman | 57 | €4,349,890 | |
Andre Schulten (50) Chief Financial Officer | 50 | €2,848,489 | |
Mary Lynn Ferguson-McHugh (60) Chief Exec. Officer of Family Care, P, and G Ventures | 60 | €2,778,448 | |
Shailesh G. Jejurikar (53) Chief Operating Officer | 53 | €2,648,992 | |
Stephen D. Bishop (56) Chief Exec. Officer of Health Care | 56 | €2,621,146 | |
Carolyn M. Tastad (59) Group Pres of North America and Chief Sales Officer | 59 | €2,422,548 | |
Michael G. Homan (58) Sr. VP, Chief Accounting Officer, and Principal Accounting Officer | 58 | ||
Damon D. Jones (46) Chief Communications Officer | 46 | ||
Ken Patel | |||
Deborah Platt Majoras (57) Chief Legal Officer and Sec. | 57 | ||
John T. Chevalier | |||
Vittorio Cretella |
The Procter & Gamble Company provides branded consumer packaged goods to consumers in North and Latin America, Europe, the Asia Pacific, Greater China, India, the Middle East, and Africa. It operates in five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments; and antiperspirants and deodorants, personal cleansing, and skin care products under the Head & Shoulders, Herbal Essences, Pantene, Rejoice, Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.
- Consumer Staples > Household & Personal Products
- Procter & Gamble Co., One Procter & Gamble Plaza, Cincinnati 45202, United States
- 513 983 1100
- Investor relations
Dividends
Ex-dividend date | 20 Oct 2022 | Frequency | Quarterly | Annual dividend | +3.48% |
---|---|---|---|---|---|
Next dividend | N/A | Dividend yield | 2.48% | Growth period | 4 years |
Last dividend date | Yield 3 years | 2.62% | Growth 3 years | +6.21% | |
Last dividend | Yield 5 years | 2.59% | Growth 5 years | N/A |
Profit margin
Debt to assets
Cash flow
Balance sheet
(in millions USD) | 29 Sep 2022 | 29 Jun 2022 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | $6,710 | $7,214 | |||
Short term investments | |||||
Net receivables | $5,720 | $5,143 | |||
Inventory | $7,590 | $6,924 | |||
Other current assets | |||||
Total current assets | $22,521 | $21,653 | |||
Long term investments | $93 | $140 | |||
Property, plant & equipment | $20,593 | $21,955 | |||
Goodwill | $38,761 | $39,700 | |||
Intangible assets | $23,465 | $23,679 | |||
Other assets | $10,849 | $10,081 | |||
Deferred long term asset charges | |||||
Total assets | $116,282 | $117,208 | |||
Current liabilities | |||||
Accounts payable | $14,845 | $14,882 | |||
Short long term debt | $11,717 | $3,647 | |||
Other current liabilities | $3,674 | ||||
Total current liabilities | $36,618 | $33,081 | |||
Long term debt | $21,286 | $22,848 | |||
Other liabilities | $14,044 | $13,830 | |||
Deferred long term liabilities | |||||
Minority interest | $259 | $265 | |||
Total liabilities | $71,948 | $70,354 | |||
Stockholders' equity | |||||
Stock option warrants | |||||
Common stock | $4,009 | $4,009 | |||
Retained earnings | $114,163 | $112,429 | |||
Treasury stock | -$140,886 | -$136,487 | |||
Capital surplus | $65,955 | $65,795 | |||
Other stockholder equity | -$13,681 | -$13,105 | |||
Total stockholder equity | $43,241 | $45,746 | |||
Net tangible assets | -$18,985 | -$17,633 |
(in millions USD) | 2022 | 2021 | ||
---|---|---|---|---|
Current assets | ||||
Cash | $7,214 | $10,288 | ||
Short term investments | ||||
Net receivables | $5,143 | $4,725 | ||
Inventory | $6,924 | $5,983 | ||
Other current assets | ||||
Total current assets | $21,653 | $23,091 | ||
Long term investments | $140 | $192 | ||
Property, plant & equipment | $21,955 | $22,494 | ||
Goodwill | $39,700 | $40,924 | ||
Intangible assets | $23,679 | $23,642 | ||
Other assets | $10,081 | $8,964 | ||
Deferred long term asset charges | ||||
Total assets | $117,208 | $119,307 | ||
Current liabilities | ||||
Accounts payable | $14,882 | $13,720 | ||
Short long term debt | $3,647 | $3,620 | ||
Other current liabilities | $3,674 | $4,019 | ||
Total current liabilities | $33,081 | $33,132 | ||
Long term debt | $22,848 | $23,099 | ||
Other liabilities | $13,830 | $15,791 | ||
Deferred long term liabilities | ||||
Minority interest | $265 | $276 | ||
Total liabilities | $70,354 | $72,653 | ||
Stockholders' equity | ||||
Stock option warrants | ||||
Common stock | $4,009 | $4,009 | ||
Retained earnings | $112,429 | $106,374 | ||
Treasury stock | -$136,487 | -$129,723 | ||
Capital surplus | $65,795 | $64,848 | ||
Other stockholder equity | -$13,105 | -$14,750 | ||
Total stockholder equity | $45,746 | $45,508 | ||
Net tangible assets | -$17,633 | -$19,058 |
Income statement
(in millions USD) | 29 Sep 2022 | 29 Jun 2022 | |||
---|---|---|---|---|---|
Revenue | |||||
Total revenue | $20,612 | $19,515 | |||
Cost of revenue | $10,846 | $10,620 | |||
Gross profit | $9,766 | $8,895 | |||
Operating activities | |||||
Research & development | |||||
Selling, general & administrative | $4,832 | $4,621 | |||
Non-recurring | |||||
Other operating expenses | |||||
Total operating expenses | $15,678 | $15,241 | |||
Operating income | $4,934 | $4,274 | |||
Income from continuing operations | |||||
Net other income | $63 | -$624 | |||
EBIT | $4,934 | $4,274 | |||
Interest expense | -$123 | -$115 | |||
Income before tax | $4,997 | $3,650 | |||
Income tax expense | $1,034 | $592 | |||
Minority interest | $259 | $265 | |||
Net income from continuing ops | $3,963 | $3,058 | |||
Non-recurring events | |||||
Discontinued operations | |||||
Extraordinary items | |||||
Effect of accounting change | |||||
Other items | |||||
Net income | |||||
Net income | $3,939 | $3,052 | |||
Income (for common shares) | $3,868 | $2,979 |
(in millions USD) | 2022 | 2021 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | $80,187 | $76,118 | ||
Cost of revenue | $41,975 | $36,974 | ||
Gross profit | $38,212 | $39,144 | ||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $19,518 | $20,351 | ||
Non-recurring | ||||
Other operating expenses | ||||
Total operating expenses | $61,493 | $57,325 | ||
Operating income | $18,694 | $18,793 | ||
Income from continuing operations | ||||
Net other income | -$699 | -$1,178 | ||
EBIT | $18,694 | $18,793 | ||
Interest expense | -$439 | -$502 | ||
Income before tax | $17,995 | $17,615 | ||
Income tax expense | $3,202 | $3,263 | ||
Minority interest | $265 | $276 | ||
Net income from continuing ops | $14,793 | $14,352 | ||
Non-recurring events | ||||
Discontinued operations | ||||
Extraordinary items | ||||
Effect of accounting change | ||||
Other items | ||||
Net income | ||||
Net income | $14,742 | $14,306 | ||
Income (for common shares) | $14,461 | $14,035 |
Cash flows
(in millions USD) | 29 Sep 2022 | 29 Jun 2022 | |||
---|---|---|---|---|---|
Net income | $3,939 | $3,052 | |||
Operating activities | |||||
Depreciation | $663 | $722 | |||
Net income adjustments | $60 | $134 | |||
Change in accounts receivable | -$740 | $222 | |||
Changes in liabilities | $1,495 | $82 | |||
Changes in inventory | -$893 | $5 | |||
Changes in other operating activities | -$454 | -$504 | |||
Total cash flows from operations | $4,070 | $3,713 | |||
Investing activities | |||||
Capital expenditures | -$890 | -$692 | |||
Investments | $55 | -$1 | |||
Other cash flows from investing | |||||
Total cash flows from investing | -$832 | -$682 | |||
Financing activities | |||||
Dividends paid | -$2,255 | -$2,262 | |||
Sale and purchase of stock | |||||
Net borrowings | $2,560 | -$851 | |||
Other cash flows from financing | |||||
Total cash flows from financing | -$3,507 | -$4,158 | |||
Effect of exchange rate | -$235 | -$185 | |||
Change in cash and equivalents | -$504 | -$1,312 |
(in millions USD) | 2022 | 2021 | ||
---|---|---|---|---|
Net income | $14,742 | $14,306 | ||
Operating activities | ||||
Depreciation | $2,807 | $2,735 | ||
Net income adjustments | $321 | $959 | ||
Change in accounts receivable | -$694 | -$342 | ||
Changes in liabilities | $1,429 | $1,391 | ||
Changes in inventory | -$1,247 | -$309 | ||
Changes in other operating activities | -$635 | -$369 | ||
Total cash flows from operations | $16,723 | $18,371 | ||
Investing activities | ||||
Capital expenditures | -$3,156 | -$2,787 | ||
Investments | $3 | -$55 | ||
Other cash flows from investing | ||||
Total cash flows from investing | -$4,424 | -$2,834 | ||
Financing activities | ||||
Dividends paid | -$8,770 | -$8,263 | ||
Sale and purchase of stock | ||||
Net borrowings | $1,892 | -$3,903 | ||
Other cash flows from financing | ||||
Total cash flows from financing | -$14,876 | -$21,531 | ||
Effect of exchange rate | -$497 | $101 | ||
Change in cash and equivalents | -$3,074 | -$5,893 |